You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

THEOLAIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Theolair, and what generic alternatives are available?

Theolair is a drug marketed by 3M and Medicis and is included in six NDAs.

The generic ingredient in THEOLAIR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Theolair

A generic version of THEOLAIR was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for THEOLAIR?
  • What are the global sales for THEOLAIR?
  • What is Average Wholesale Price for THEOLAIR?
Summary for THEOLAIR
US Patents:0
Applicants:2
NDAs:6
Raw Ingredient (Bulk) Api Vendors: 171
Patent Applications: 6,353
DailyMed Link:THEOLAIR at DailyMed
Drug patent expirations by year for THEOLAIR

US Patents and Regulatory Information for THEOLAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m THEOLAIR theophylline SOLUTION;ORAL 086107-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 089132-001 Jul 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 088369-001 Jul 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Medicis THEOLAIR theophylline TABLET;ORAL 086399-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Medicis THEOLAIR theophylline TABLET;ORAL 086399-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.